{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T05:06:01Z","timestamp":1775279161164,"version":"3.50.1"},"reference-count":32,"publisher":"Japanese Society of Toxicology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2131\/jts.51.239","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T22:14:01Z","timestamp":1774995241000},"page":"239-249","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of cytotoxicity of vesnarinone causing drug-induced agranulocytosis by a myeloperoxidase-like nonenzymatic metabolic approach using hypochlorous acid and application of the constructed assay method"],"prefix":"10.2131","volume":"51","author":[{"given":"Toshihisa","family":"Koga","sequence":"first","affiliation":[{"name":"Department of Drug Metabolism and Pharmacokinetics, Nonclinical Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Sahara","sequence":"additional","affiliation":[{"name":"Department of Drug Metabolism and Pharmacokinetics, Nonclinical Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadaaki","family":"Ohtani","sequence":"additional","affiliation":[{"name":"Medicinal Chemistry Research Institute, Otsuka Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Aizawa, S., Nakano, M., Yaguchi, M., Kuriyama, Y., Iwase, O., Toyama, K., Tanaka, K., Hoshi, H., Sugimoto, K., Kaido, A., Imai, T., Nabeshima, R. and Handa, H. (1997): Possible involvement of bone marrow stromal cells in agranulocytosis caused by vesnarinone treatment. Acta Haematol., <b>98<\/b>, 140-146.","DOI":"10.1159\/000203608"},{"key":"2","unstructured":"Beilke, M.A., Collins-Lech, C. and Sohnle, P.G. (1987): Effects of dimethyl sulfoxide on the oxidative function of human neutrophils. J. Lab. Clin. Med., <b>110<\/b>, 91-96."},{"key":"3","doi-asserted-by":"crossref","unstructured":"Bertolet, B.D. (2004): Precautions for use and adverse effects of vesnarinone: potential mechanisms and future therapies. Drug Saf., <b>27<\/b> (Suppl 1), 11-18.","DOI":"10.2165\/00002018-200427001-00003"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Cohn, J.N., Goldstein, S.O., Greenberg, B.H., Lorell, B.H., Bourge, R.C., Jaski, B.E., Gottlieb, S.O., McGrew, F. 3rd, DeMets, D.L. and White, B.G.; Vesnarinone Trial Investigators. (1998): A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. N. Engl. J. Med., <b>339<\/b>, 1810-1816.","DOI":"10.1056\/NEJM199812173392503"},{"key":"5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/01.JAA.0000000000000054","author":"J. Cossey","year":"2024","unstructured":"Cossey, J. and Cote, M.C. (2024): Evaluation and management of febrile neutropenia in patients with cancer. JAAPA, <b>37<\/b>, 16-20.","journal-title":"Journal of the American Academy of Physician Assistants","ISSN":"https:\/\/id.crossref.org\/issn\/0893-7400","issn-type":"print"},{"key":"6","unstructured":"Data on file. Tokyo, Japan; Otsuka Pharmaceutical Co., Ltd., 1996."},{"key":"7","doi-asserted-by":"crossref","unstructured":"Ellrodt, A.G., Murata, G.H., Riedinger, M.S., Stewart, M.E., Mochizuki, C. and Gray, R. (1984): Severe neutropenia associated with sustained-release procainamide. Ann. Intern. Med., <b>100<\/b>, 197-201.","DOI":"10.7326\/0003-4819-100-2-197"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Feldman, A.M., Bristow, M.R., Parmley, W.W., Carson, P.E., Pepine, C.J., Gilbert, E.M., Strobeck, J.E., Hendrix, G.H., Powers, E.R., Bain, R.P. and White, B.G.; Vesnarinone Study Group. (1993): Effects of vesnarinone on morbidity and mortality in patients with heart failure. N. Engl. J. Med., <b>329<\/b>, 149-155.","DOI":"10.1056\/NEJM199307153290301"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Gardner, I., Leeder, J.S., Chin, T., Zahid, N. and Uetrecht, J.P. (1998): A comparison of the covalent binding of clozapine and olanzapine to human neutrophils <i>in vitro<\/i> and <i>in vivo.<\/i> Mol. Pharmacol., <b>53<\/b>, 999-1008.","DOI":"10.1016\/S0026-895X(24)13269-5"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Geib, T., Thulasingam, M., Haeggstr\u00f6m, J.Z. and Sleno, L. (2020): Investigation of clozapine and olanzapine reactive metabolite formation and protein binding by liquid chromatography-tandem mass spectrometry. Chem. Res. Toxicol., <b>33<\/b>, 2420-2431.","DOI":"10.1021\/acs.chemrestox.0c00191"},{"key":"11","doi-asserted-by":"crossref","unstructured":"G\u00fcrsoy, M., Haznedaro\u011flu, I.C., Celik, I., Sayinalp, N., Ozcebe, O.I. and D\u00fcndar, S.V. (1996): Agranulocytosis, plasmacytosis, and thrombocytosis followed by a leukemoid reaction due to acute acetaminophen toxicity. Ann. Pharmacother., <b>30<\/b>, 762-765.","DOI":"10.1177\/106002809603000710"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Hass, W.K., Easton, J.D., Adams, H.P. Jr., Pryse-Phillips, W., Molony, B.A., Anderson, S. and Kamm, B.; Ticlopidine Aspirin Stroke Study Group. (1989): A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N. Engl. J. Med., <b>321<\/b>, 501-507.","DOI":"10.1056\/NEJM198908243210804"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Johnston, A. and Uetrecht, J. (2015): Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis. Expert Opin. Drug Metab. Toxicol., <b>11<\/b>, 243-257.","DOI":"10.1517\/17425255.2015.985649"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Koga, T., Sahara, Y., Ohtani, T., Yosuke, K. and Umehara, K. (2024): Possible nonimmunological toxicological mechanisms of vesnarinone-associated agranulocytosis in HL-60 cells: role of reduced glutathione as cytotoxic defense. J. Toxicol. Sci., <b>49<\/b>, 95-103.","DOI":"10.2131\/jts.49.95"},{"key":"15","unstructured":"Kuzell, W.C., Koets, P., Schaffarzick, R.W. and Naugler, W.E. (1955): Variation of blood glutathione during neutropenia; case report. Stanford Med. Bull., <b>13<\/b>, 284-289."},{"key":"16","unstructured":"Lieberman, J.A., Johns, C.A., Kane, J.M., Rai, K., Pisciotta, A.V., Saltz, B.L. and Howard, A. (1988): Clozapine-induced agranulocytosis: non-cross-reactivity with other psychotropic drugs. J. Clin. Psychiatry, <b>49<\/b>, 271-277."},{"key":"17","doi-asserted-by":"crossref","unstructured":"Liou, S.Y. and Dodd, M.C. (2021): Evaluation of hydroxyl radical and reactive chlorine species generation from the superoxide\/hypochlorous acid reaction as the basis for a novel advanced oxidation process. Water Res., <b>200<\/b>, 117142.","DOI":"10.1016\/j.watres.2021.117142"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez, E., Aranda, A., de, M.Y., Rodr\u00edguez, D., L\u00f3pez, M.R. and Albaladejo, J. (2002): Atmospheric DMSO degradation in the gas phase: Cl-DMSO reaction. Temperature dependence and products. Environ. Sci. Technol., <b>36<\/b>, 1226-1230.","DOI":"10.1021\/es010169s"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Ono, K., Kurohara, K., Yoshihara, M., Shimamoto, Y. and Yamaguchi, M. (1991): Agranulocytosis caused by ticlopidine and its mechanism. Am. J. Hematol., <b>37<\/b>, 239-242.","DOI":"10.1002\/ajh.2830370405"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Panasenko, O.M., Gorudko, I.V. and Sokolov, A.V. (2013): Hypochlorous acid as a precursor of free radicals in living systems. Biochemistry (Mosc.), <b>78<\/b>, 1466-1489.","DOI":"10.1134\/S0006297913130075"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Pereira, A. and Dean, B. (2006): Clozapine bioactivation induces dose-dependent, drug-specific toxicity of human bone marrow stromal cells: a potential <i>in vitro<\/i> system for the study of agranulocytosis. Biochem. Pharmacol., <b>72<\/b>, 783-793.","DOI":"10.1016\/j.bcp.2006.06.006"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Rashid, M.H., Tran, N.H., Babu, D., Lockhart, S., Eldalal, O., Tran, P., Reiz, B. and Siraki, A.G. (2025): Sulforaphane treatment of HL-60 cells protects against clozapine toxicity and protein covalent binding: implications for clozapine-induced agranulocytosis. Chem. Biol. Interact., <b>418<\/b>, 111581.","DOI":"10.1016\/j.cbi.2025.111581"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Rosenblum, W.I. and El-Sabban, F. (1982): Dimethyl sulfoxide (DMSO) and glycerol, hydroxyl radical scavengers, impair platelet aggregation within and eliminate the accompanying vasodilation of, injured mouse pial arterioles. Stroke, <b>13<\/b>, 35-39.","DOI":"10.1161\/01.STR.13.1.35"},{"key":"24","doi-asserted-by":"crossref","unstructured":"S\u00e9guin, B. and Uetrecht, J. (2003): The danger hypothesis applied to idiosyncratic drug reactions. Curr. Opin. Allergy Clin. Immunol., <b>3<\/b>, 235-242.","DOI":"10.1097\/00130832-200308000-00001"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Sernoskie, S.C., Jee, A. and Uetrecht, J. (2023): The role of myeloperoxidase in clozapine-induced inflammation: a mechanistic update for idiosyncratic drug-induced agranulocytosis. Int. J. Mol. Sci., <b>24<\/b>, 1243.","DOI":"10.3390\/ijms24021243"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Sernoskie, S.C., Bonneil, \u00c9., Thibault, P., Jee, A. and Uetrecht, J. (2024): Involvement of extracellular vesicles in the proinflammatory response to clozapine: implications for clozapine-induced agranulocytosis. J. Pharmacol. Exp. Ther., <b>388<\/b>, 827-845.","DOI":"10.1124\/jpet.123.001970"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Torii-Goto, A., Yoshimi, A., Tashiro, Y., Ukigai, M., Matsumoto, A., Ozaki, N. and Noda, Y. (2022): A reactive metabolite of clozapine induces hematopoietic toxicity in HL-60 cells undergoing granulocytic differentiation through its effect on glutathione metabolism. Biol. Pharm. Bull., <b>45<\/b>, 1232-1237.","DOI":"10.1248\/bpb.b22-00045"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Tschen, A.C., Rieder, M.J., Oyewumi, L.K. and Freeman, D.J. (1999): The cytotoxicity of clozapine metabolites: implications for predicting clozapine-induced agranulocytosis. Clin. Pharmacol. Ther., <b>65<\/b>, 526-532.","DOI":"10.1016\/S0009-9236(99)70072-X"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Uetrecht, J.P. (1992): The role of leukocyte-generated reactive metabolites in the pathogenesis of idiosyncratic drug reactions. Drug Metab. Rev., <b>24<\/b>, 299-366.","DOI":"10.3109\/03602539208996297"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Uetrecht, J. and Naisbitt, D.J. (2013): Idiosyncratic adverse drug reactions: current concepts. Pharmacol. Rev., <b>65<\/b>, 779-808.","DOI":"10.1124\/pr.113.007450"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Vissers, M.C. and Winterbourn, C.C. (1995): Oxidation of intracellular glutathione after exposure of human red blood cells to hypochlorous acid. Biochem. J., <b>307<\/b>, 57-62.","DOI":"10.1042\/bj3070057"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Winterbourn, C.C. and Brennan, S.O. (1997): Characterization of the oxidation products of the reaction between reduced glutathione and hypochlorous acid. Biochem. J., <b>326<\/b>, 87-92.","DOI":"10.1042\/bj3260087"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/51\/4\/51_239\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:23:58Z","timestamp":1775276638000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/51\/4\/51_239\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.51.239","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}